IE43845L - 4-thia-1-azabicyclo [4.2.0] oct-2-ene derivatives - Google Patents

4-thia-1-azabicyclo [4.2.0] oct-2-ene derivatives

Info

Publication number
IE43845L
IE43845L IE760972A IE97276A IE43845L IE 43845 L IE43845 L IE 43845L IE 760972 A IE760972 A IE 760972A IE 97276 A IE97276 A IE 97276A IE 43845 L IE43845 L IE 43845L
Authority
IE
Ireland
Prior art keywords
formula
compounds
protective group
meaning stated
substituents
Prior art date
Application number
IE760972A
Other versions
IE43845B1 (en
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Priority to IE189/81A priority Critical patent/IE43846B1/en
Publication of IE43845L publication Critical patent/IE43845L/en
Publication of IE43845B1 publication Critical patent/IE43845B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36One oxygen atom
    • C07D263/38One oxygen atom attached in position 2
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Compounds of the formula I in which R and E have the meaning stated in Claim 1 are antibiotics which are effective against Gram-positive and Gram-negative bacteria. They are prepared by N-acylation of compounds of the formula II in which R<2> is hydrogen or a carboxyl protective group with compounds of the formula RX' in which X' has the meaning stated in Claim 1, and elimination of any carboxyl protective group present. During the reaction, intermediate protection of the sensitive substituents present in the radical R is also possible. The carboxylic acids of the formula II in which E is bromomethyl are prepared by bromination of compounds of the formula IV-b in which the substituents have the meaning stated in Claim 25 with a compound which provides bromine free radicals in the presence of an initiator which provides free radicals, with subsequent elimination of the amino protective group, or if E in the formula IV-b is a lower alkanoyloxymethyl group, by reaction of a compound of the formula VIII in which the substituents have the meaning stated in Claim 29 with a salt of a lower alkanecarboxylic acid and subsequent elimination of the amino protective group. <IMAGE> [GB1553429A]
IE972/76A 1975-05-05 1976-05-05 4-thia-1-azabicyclo/4.2.0/oct-2-ene derivatives IE43845B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE189/81A IE43846B1 (en) 1975-05-05 1976-05-05 Azetidine compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57422575A 1975-05-05 1975-05-05
US62668675A 1975-10-29 1975-10-29

Publications (2)

Publication Number Publication Date
IE43845L true IE43845L (en) 1976-11-05
IE43845B1 IE43845B1 (en) 1981-06-17

Family

ID=27076332

Family Applications (1)

Application Number Title Priority Date Filing Date
IE972/76A IE43845B1 (en) 1975-05-05 1976-05-05 4-thia-1-azabicyclo/4.2.0/oct-2-ene derivatives

Country Status (11)

Country Link
JP (1) JPS51136694A (en)
AU (1) AU500636B2 (en)
CH (3) CH623331A5 (en)
DE (1) DE2619458A1 (en)
DK (1) DK194776A (en)
ES (3) ES447577A1 (en)
FR (2) FR2324639A1 (en)
GB (2) GB1553429A (en)
IE (1) IE43845B1 (en)
LU (1) LU74873A1 (en)
NL (1) NL7604797A (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4122086A (en) * 1977-07-26 1978-10-24 Smithkline Corporation Isopenicillins
FR2505840A1 (en) * 1981-05-13 1982-11-19 Roussel Uclaf NOVEL PRODUCTS DERIVED FROM 2-AMINO THIAZOLYL 2-OXYIMINO ACETAMIDO BICYCLO-OCTENE CARBOXYLIC ACID, PROCESS FOR PREPARING THEM AND THEIR APPLICATION AS MEDICAMENTS
FR2552089B2 (en) * 1981-05-13 1985-10-25 Roussel Uclaf NOVEL PRODUCTS DERIVED FROM 2-AMINO THIAZOLYL ACID 2-OXYIMINO ACETAMIDO BICYCLO-OCTENE CARBOXYLIC, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
CA1262128A (en) * 1981-08-27 1989-10-03 Christian N. Hubschwerlen .beta.-lactams
FR2538389B2 (en) * 1981-10-23 1986-05-16 Roussel Uclaf NEW PRODUCTS DERIVED FROM 3-AMINO 2-OXO AZETIDINE-1-SULFAMIC ACID, NEW PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE PRODUCTS, APPLICATION OF NEW PRODUCTS AS MEDICAMENTS AND PRODUCTS NECESSARY FOR THEIR PREPARATION
FR2558467B2 (en) * 1981-10-23 1987-03-20 Roussel Uclaf NEW PRODUCT DERIVED FROM 3-AMINO 2-OXO AZETIDINE 1-SULPHAMIC ACID, ITS PREPARATION PROCESS, ITS USE AS A MEDICAMENT AND AN INTERMEDIATE PRODUCT NECESSARY FOR ITS PREPARATION
FR2515182B1 (en) * 1981-10-23 1986-05-09 Roussel Uclaf NOVEL PRODUCTS DERIVED FROM 3-AMINO 2-OXO AZETIDINE 1-SULFAMIC ACID, THEIR PREPARATION PROCESS, THEIR APPLICATION AS MEDICAMENTS AND THE INTERMEDIATE PRODUCTS NECESSARY FOR THEIR PREPARATION
JPS6036458A (en) * 1983-08-08 1985-02-25 Sumitomo Chem Co Ltd Method for producing β-lactam derivatives
FR2559486B1 (en) * 1984-02-13 1988-02-12 Roussel Uclaf NOVEL DERIVATIVES OF 1-DETHIA 2-THIA CEPHALOSPORANIC ACID, PROCESS FOR THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
FR2586020B2 (en) * 1985-08-09 1988-10-14 Roussel Uclaf NOVEL DERIVATIVES OF 1-DETHIA 2-THIA CEPHALOSPORANIC ACID, PROCESS FOR THEIR PREPARATION, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2588867B1 (en) * 1985-10-23 1988-12-09 Roussel Uclaf NOVEL PRODUCTS DERIVED FROM THE 3-AMINO 2-OXO AZETIDINE SERIES, THEIR PREPARATION PROCESS AND THEIR APPLICATION
FR2610630B2 (en) * 1987-02-06 1989-05-26 Roussel Uclaf NOVEL DERIVATIVES OF 1-DETHIA 2-THIA CEPHALOSPORANIC ACID, PROCESS FOR THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2046823A1 (en) * 1970-09-23 1972-03-30 Farbwerke Hoechst AG vormals Meister Lucius & Brüning, 6000 Frankfurt New azetidinones (2) and processes for their preparation

Also Published As

Publication number Publication date
ES447577A1 (en) 1977-12-01
ES460722A1 (en) 1978-05-01
DE2619458A1 (en) 1976-11-18
CH623331A5 (en) 1981-05-29
NL7604797A (en) 1976-11-09
CH624670A5 (en) 1981-08-14
FR2324639A1 (en) 1977-04-15
LU74873A1 (en) 1977-01-12
ES460746A1 (en) 1978-10-01
DK194776A (en) 1976-11-06
IE43845B1 (en) 1981-06-17
FR2313362B1 (en) 1979-03-23
AU500636B2 (en) 1979-05-31
JPS51136694A (en) 1976-11-26
GB1553429A (en) 1979-09-26
FR2313362A1 (en) 1976-12-31
AU1366976A (en) 1977-11-10
CH627475A5 (en) 1982-01-15
FR2324639B1 (en) 1978-11-03
GB1553430A (en) 1979-09-26

Similar Documents

Publication Publication Date Title
JPS5756485A (en) Cephem of penam compound and its preparation
IE43845L (en) 4-thia-1-azabicyclo [4.2.0] oct-2-ene derivatives
JPS5452096A (en) Cephem compound, its preparation and bacteriostatic agent containing the same
IE37767B1 (en) Derivatives of 7beta-amino-cephem-3-ol-4-carboxylic acids
JPS5543011A (en) 7-halothiazolylalkoxyiminoacetamido-3-cephem compound
IE33535L (en) Penicillins
GB1499026A (en) Adriamycin esters
JPS5547688A (en) Novel cephem compound and its preparation
GB8410396D0 (en) Carbocyclic compounds
IE44069L (en) Noroxymorphones
ES8504203A1 (en) Antibacterial penem derivatives.
GB1449656A (en) Cephalosporin derivatives and their preparation
IE44433L (en) Derivatives of thienamycin and its isomers
JPS5444695A (en) 3,7-disubstituted-3-cephem-4-carboxylic acid and its salt and their preparation
JPS5265263A (en) Azetidinone compounds
ES424204A1 (en) 1-oxadethiapenicillanic acid derivatives
GB985966A (en) Thiazine derivatives
JPS54115354A (en) Biphenylylglycine derivative
JPS55139388A (en) Cephalosporin derivative
JPS5767581A (en) Beta-lactam derivative
GB1042481A (en) Dipeptide derivatives
IE43912L (en) 7-methoxycephalosporin derivatives.
GB1533413A (en) Penicillins
JPS56122383A (en) Novel cephalosporin compound and its preparation
JPS55100365A (en) Quinoline derivative and its preparation